GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with (S)-mcg-III-027-D05.

Analyse Crystal structure of HIV-1 LM/HT clade A/E CRF01 GP120 core in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6ONV
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 LM/HT clade A/E CRF01 GP120
UniProt
A0A0M3KKW9
Ligands
MWA, NAG
Pockets
5 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 LM/HT clade A/E CRF01 GP120protein33714% helix, 34% strandA0A0M3KKW9

Ligands and binding sites

  • MWA · (3S)-N-(4-chloro-3-fluorophenyl)-1-(methylsulfonyl) piperidine-3-carboxamide · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1680.570.8818MWA
2820.570.8720empty
3880.510.8319NAG
4540.390.8118empty
5800.360.7616empty

Modifications

Observed in the structure: 10 glycan, 8 disulfide (N-glycosylation, disulfide).

Compared structures

  • 6ONV · Crystal structure of HIV-1 LM/HT Clade A/E CRF01 gp120 core in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.